Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

Authors

Keywords

Journal

Volume 70, Issue 21, Pages 1980-1983

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2008-04-10

DOI

10.1212/01.wnl.0000312381.29287.ff

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now